# Krystal Biotech, Inc.: Form 8-K, filed Aug 7, 2023

- Company: [Krystal Biotech, Inc.](/companies/krys.md) (CIK 1711279)
- Form: 8-K
- Filed: 2023-08-07
- Accepted by EDGAR: Aug 7, 2023, 08:18 ET
- Period: 2023-08-02
- Accession: 0001711279-23-000069
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1711279/000171127923000069/krys-20230802.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1711279/000171127923000069/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1711279/000171127923000069/krys-20230802.htm

Filed Aug 7, 2023.
Source: SEC EDGAR, the filing index for accession 0001711279-23-000069. Last ingested by Listed: Nov 2, 2026, 07:08 ET. No prices; not investment advice.